n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate has been researched along with Lymphoma, Non-Hodgkin in 1 studies
*Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hazuku, T; Kawano, K; Kodama, Y; Maruyama, R; Miyazaki, Y; Ohtsuka, E; Saburi, M; Sakata, M; Takata, H; Urabe, S; Wada, J | 1 |
1 other study(ies) available for n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon].
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Doxorubicin; Humans; Lymphadenopathy; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Thiotepa; Transplantation, Autologous; Vincristine | 2022 |